Cancer research
Liquid Biopsy Market Set to Transform Oncology with Robust Growth
The global liquid biopsy market is projected to undergo significant transformation in the coming years, driven by the increasing prevalence of cancer, adoption of minimally invasive diagnostic tests, and advances in biomarker discovery. The market is expected to grow from USD 11.41 Billion in 2024 to USD 30.65